Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 264

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Vitamin E and Alzheimer disease: the basis for additional clinical trials

Open access
Grundman, Michael·2000·The American Journal of Clinical Nutrition
DOI 10.1093/ajcn/71.2.630s
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/71.2.630s

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 74

  1. Selkoe, 1996, Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer’s disease, Cold Spring Harb Symp Quant Biol, 61, 587, 10.1101/SQB.1996.061.01.059 · DOI
  2. Beal, 1996, Mitochondria, free radicals, and neurodegeneration, Curr Opin Neurobiol, 6, 661, 10.1016/S0959-4388(96)80100-0 · DOI · Paper page
  3. Terry, 1996, The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis, J Neuropathol Exp Neurol, 55, 1023, 10.1097/00005072-199655100-00001 · doi:10.1097/00005072-199655100-00001 · Paper page
  4. Jackson, 1994, Neurotrophin regulation of energy homeostasis in the central nervous system, Dev Neurosci, 16, 285, 10.1159/000112121 · DOI
  5. Halliwell, 1985, Oxygen radicals and the nervous system, Trends Neurosci, 8, 22, 10.1016/0166-2236(85)90010-4 · DOI · Paper page
  6. Balazs, 1994, Evidence of an oxidative challenge in the Alzheimer’s brain, Neurochem Res, 19, 1131, 10.1007/BF00965146 · DOI · Paper page
  7. Palmer, 1994, Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer’s disease, Brain Res, 645, 338, 10.1016/0006-8993(94)91670-5 · DOI · Paper page
  8. Premkumar, 1995, Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer’s disease, J Neurochem, 65, 1399, 10.1046/j.1471-4159.1995.65031399.x · DOI · Paper page
  9. Good, 1996, Evidence of neuronal oxidative damage in Alzheimer’s disease, Am J Pathol, 149, 21
  10. Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer’s disease, J Neurosci, 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997 · DOI · Paper page
  11. van der Vliet, 1997, Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity, J Biol Chem, 272, 7617, 10.1074/jbc.272.12.7617 · DOI · Paper page
  12. Nagra, 1997, Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis, J Neuroimmunol, 78, 97, 10.1016/S0165-5728(97)00089-1 · DOI · Paper page
  13. Schipper, 1995, Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain, Ann Neurol, 37, 758, 10.1002/ana.410370609 · DOI · Paper page
  14. Smith, 1994, Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease, Am J Pathol, 145, 42
  15. Yan, 1994, Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc Natl Acad Sci U S A, 91, 7787, 10.1073/pnas.91.16.7787 · DOI · Paper page
  16. Smith, 1996, Oxidative damage in Alzheimer’s, Nature, 382, 120, 10.1038/382120b0 · DOI · Paper page
  17. Furuta, 1995, Localization of superoxide dismutases in Alzheimer’s disease and Down’s syndrome neocortex and hippocampus, Am J Pathol, 146, 357
  18. Pappolla, 1992, Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease, Am J Pathol, 140, 621
  19. Pike, 1993, Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J Neurosci, 13, 1676, 10.1523/JNEUROSCI.13-04-01676.1993 · DOI · Paper page
  20. Simmons, 1994, Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol Pharmacol, 45, 373, 10.1016/S0026-895X(25)10007-2 · DOI · Paper page
  21. Butterfield, 1994, β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer’s disease, Biochem Biophys Res Commun, 200, 710, 10.1006/bbrc.1994.1508 · DOI · Paper page
  22. Mutisya, 1994, Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease, J Neurochem, 63, 2179, 10.1046/j.1471-4159.1994.63062179.x · DOI · Paper page
  23. Parker, 1994, Electron transport chain defects in Alzheimer’s disease brain, Neurology, 44, 1090, 10.1212/WNL.44.6.1090 · DOI · Paper page
  24. Beal, 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci, 16, 125, 10.1016/0166-2236(93)90117-5 · DOI · Paper page
  25. Davis, 1997, Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease, Proc Natl Acad Sci U S A, 94, 4526, 10.1073/pnas.94.9.4526 · DOI · Paper page
  26. Connor, 1992, Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer’s disease, J Neurosci Res, 31, 327, 10.1002/jnr.490310214 · DOI · Paper page
  27. Grundke-Iqbal, 1990, Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia, Acta Neuropathol (Berl), 81, 105, 10.1007/BF00334497 · DOI · Paper page
  28. Multhaup, 1996, The amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I), Science, 271, 1406, 10.1126/science.271.5254.1406 · DOI · Paper page
  29. Chen, 1994, Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer’s disease and from nondemented controls, Int J Neurosci, 75, 83, 10.3109/00207459408986291 · DOI
  30. Adams, 1991, Alzheimer’s and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E, Mol Chem Neuropathol, 14, 213, 10.1007/BF03159937 · DOI · Paper page
  31. Jeandel, 1989, Lipid peroxidation and free radical scavengers in Alzheimer’s disease, Gerontology, 35, 275, 10.1159/000213037 · DOI · Paper page
  32. Perrin, 1990, Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study, Gerontology, 36, 306, 10.1159/000213215 · DOI
  33. Metcalfe, 1989, Vitamin E concentrations in human brain of patients with Alzheimer’s disease, fetuses with Down’s syndrome, centenarians, and controls, Neurochem Res, 14, 1209, 10.1007/BF00965511 · DOI
  34. Jackson, 1988, Vitamin E and Alzheimer’s disease in subjects with Down’s syndrome, J Ment Defic Res, 32, 479
  35. Zaman, 1992, Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s disease, Age Ageing, 21, 91, 10.1093/ageing/21.2.91 · DOI · Paper page
  36. Goodman, 1994, Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury, Exp Neurol, 128, 1, 10.1006/exnr.1994.1107 · DOI · Paper page
  37. Behl, 1992, Vitamin E protects nerve cells from amyloid beta protein toxicity, Biochem Biophys Res Commun, 186, 944, 10.1016/0006-291X(92)90837-B · DOI · Paper page
  38. Murphy, 1990, Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake, FASEB J, 4, 1624, 10.1096/fasebj.4.6.2180770 · DOI · Paper page
  39. Trojanowski, 1995, Phosphorylation of paired helical filament tau in Alzheimer’s disease neurofibrillary lesions: focusing on phosphatases, FASEB J, 9, 1570, 10.1096/fasebj.9.15.8529836 · DOI · Paper page
  40. Smith, 1995, Radical AGEing in Alzheimer’s disease, Trends Neurosci, 18, 172, 10.1016/0166-2236(95)93897-7 · DOI · Paper page
  41. Schweers, 1995, Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments, Proc Natl Acad Sci U S A, 92, 8463, 10.1073/pnas.92.18.8463 · DOI · Paper page
  42. Pillai, 1993, Alpha-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E, Lipids, 28, 1101, 10.1007/BF02537077 · DOI
  43. Monji, 1994, Effect of dietary vitamin E on lipofuscin accumulation with age in the rat brain, Brain Res, 634, 62, 10.1016/0006-8993(94)90258-5 · DOI
  44. Meydani, 1988, Effect of dietary vitamin E and selenium on susceptibility of brain regions to lipid peroxidation, Lipids, 23, 405, 10.1007/BF02535510 · DOI
  45. Vatassery, 1988, Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats, J Neurochem, 51, 621, 10.1111/j.1471-4159.1988.tb01083.x · DOI
  46. Carney, 1991, Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone, Proc Natl Acad Sci U S A, 88, 3633, 10.1073/pnas.88.9.3633 · DOI · Paper page
  47. Socci, 1995, Chronic antioxidant treatment improves the cognitive performance of aged rats, Brain Res, 693, 88, 10.1016/0006-8993(95)00707-W · DOI · Paper page
  48. Ichitani, 1992, Learning behaviour in chronic vitamin E-deficient and -supplemented rats: radial arm maze learning and passive avoidance response, Behav Brain Res, 51, 157, 10.1016/S0166-4328(05)80209-8 · DOI
  49. Wortwein, 1994, Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A, Exp Neurol, 125, 15, 10.1006/exnr.1994.1002 · DOI
  50. Hara, 1990, Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus, Brain Res, 510, 335, 10.1016/0006-8993(90)91386-U · DOI · Paper page
  51. Hsiao, 1995, Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins, Neuron, 15, 1203, 10.1016/0896-6273(95)90107-8 · DOI · Paper page
  52. 1993, Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease, N Engl J Med, 328, 176, 10.1056/NEJM199301213280305 · DOI · Paper page
  53. Kitagawa, 1989, Effects of elevated d-alpha(RRR)-tocopherol dosage in man, J Nutr Sci Vitaminol (Tokyo), 35, 133, 10.3177/jnsv.35.133 · DOI
  54. Bierenbaum, 1985, The effect of supplemental vitamin E on serum parameters in diabetic, post coronary and normal subjects, Nutr Rep Int, 31, 1171
  55. Stampfer, 1983, Effect of vitamin E on lipids, Am J Clin Pathol, 79, 714, 10.1093/ajcp/79.6.714 · DOI
  56. Tsai, 1978, Study on the effect of megavitamin E supplementation in man, Am J Clin Nutr, 31, 831, 10.1093/ajcn/31.5.831 · DOI
  57. Gillilan, 1977, Quantitative evaluation of vitamin E in the treatment of angina pectoris, Am Heart J, 93, 444, 10.1016/S0002-8703(77)80406-7 · DOI
  58. Pappert, 1996, Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson’s disease patients: dose-response study and correlations with plasma levels, Neurology, 47, 1037, 10.1212/WNL.47.4.1037 · DOI
  59. Brin, 1989, Relationship between dose of vitamin E administered and blood levels, Ann N Y Acad Sci, 570, 421, 10.1111/j.1749-6632.1989.tb14945.x · DOI
  60. Anderson, 1974, A double-blind trial of vitamin E in angina pectoris, Am J Clin Nutr, 27, 1174, 10.1093/ajcn/27.10.1174 · doi:10.1093/ajcn/27.10.1174
  61. McBee, 1997, Hormone replacement therapy and other potential treatments for dementias, Endocrinol Metab Clin North Am, 26, 329, 10.1016/S0889-8529(05)70250-4 · DOI
  62. Rubin, 1989, Very mild senile dementia of the Alzheimer type. I. Clinical assessment, Arch Neurol, 46, 379, 10.1001/archneur.1989.00520400033016 · DOI · Paper page
  63. Reisberg, 1982, The Global Deterioration Scale for assessment of primary degenerative dementia, Am J Psychiatry, 139, 1136, 10.1176/ajp.139.9.1136 · DOI · Paper page
  64. Bowen, 1997, Progression to dementia in patients with isolated memory loss, Lancet, 349, 763, 10.1016/S0140-6736(96)08256-6 · DOI · Paper page
  65. Petersen, 1995, Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals, JAMA, 273, 1274, 10.1001/jama.1995.03520400044042 · DOI · Paper page
  66. Grundman, 1996, Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment. The ADCS Cooperative Study, Neurology, 46, A403
  67. Masur, 1994, Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons, Neurology, 44, 1427, 10.1212/WNL.44.8.1427 · DOI · Paper page
  68. Tierney, 1996, Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study, Neurology, 46, 661, 10.1212/WNL.46.3.661 · DOI · Paper page
  69. Poirier, 1995, Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease, Proc Natl Acad Sci U S A, 92, 12260, 10.1073/pnas.92.26.12260 · DOI · Paper page
  70. McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  71. Farrer, 1994, Interrater agreement for diagnosis of Alzheimer’s disease: the MIRAGE Study, Neurology, 44, 652, 10.1212/WNL.44.4.652 · DOI
  72. Blacker, 1994, Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. The National Institute of Mental Health Genetics Initiative, Arch Neurol, 51, 1198, 10.1001/archneur.1994.00540240042014 · DOI · Paper page
  73. Folstein, 1975, “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  74. Galasko, 1997, An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study, Alzheimer Dis Assoc Disord, 11, S33, 10.1097/00002093-199700112-00005 · DOI · Paper page

Cited by

See all 264

Metadata

Authors
Grundman, M.
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2000-02
Volume
71
Issue
2
Pages
630S-636S
ISSN
0002-9165 (ISSN-L)
DOI
10.1093/ajcn/71.2.630s
OpenAlex
W1922689867
Cited by
264
References
18
FWCI
14.36
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitamin E and Alzheimer disease: the basis for additional clinical trials. https://app.cochat.ai/papers/10.1093/ajcn/71.2.630s
The paper
Grundman, M. (2000). Vitamin E and Alzheimer disease: the basis for additional clinical trials. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/71.2.630s

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.